Revelation Biosciences (REVB) Competitors $2.95 +0.11 (+3.87%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$2.95 0.00 (0.00%) As of 07/18/2025 07:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock REVB vs. IMNN, RLYB, SYBX, AIMD, TXMD, TRIB, NKGN, FLGC, NEUP, and MEShould you be buying Revelation Biosciences stock or one of its competitors? The main competitors of Revelation Biosciences include Imunon (IMNN), Rallybio (RLYB), Synlogic (SYBX), Ainos (AIMD), TherapeuticsMD (TXMD), Trinity Biotech (TRIB), NKGen Biotech (NKGN), Flora Growth (FLGC), Neuphoria Therapeutics (NEUP), and 23andMe (ME). These companies are all part of the "pharmaceutical products" industry. Revelation Biosciences vs. Its Competitors Imunon Rallybio Synlogic Ainos TherapeuticsMD Trinity Biotech NKGen Biotech Flora Growth Neuphoria Therapeutics 23andMe Revelation Biosciences (NASDAQ:REVB) and Imunon (NASDAQ:IMNN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability. Do institutionals & insiders believe in REVB or IMNN? 12.8% of Revelation Biosciences shares are owned by institutional investors. Comparatively, 4.5% of Imunon shares are owned by institutional investors. 2.3% of Revelation Biosciences shares are owned by company insiders. Comparatively, 6.0% of Imunon shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts recommend REVB or IMNN? Imunon has a consensus price target of $15.50, indicating a potential upside of 2,707.97%. Given Imunon's stronger consensus rating and higher possible upside, analysts plainly believe Imunon is more favorable than Revelation Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Revelation Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Imunon 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.75 Is REVB or IMNN more profitable? Revelation Biosciences' return on equity of -299.46% beat Imunon's return on equity.Company Net Margins Return on Equity Return on Assets Revelation BiosciencesN/A -299.46% -115.36% Imunon N/A -427.98%-175.03% Which has higher earnings and valuation, REVB or IMNN? Revelation Biosciences has higher earnings, but lower revenue than Imunon. Imunon is trading at a lower price-to-earnings ratio than Revelation Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRevelation BiosciencesN/AN/A-$15.04M-$307.86-0.01Imunon$500K19.36-$18.62M-$1.36-0.41 Does the media prefer REVB or IMNN? In the previous week, Revelation Biosciences had 1 more articles in the media than Imunon. MarketBeat recorded 3 mentions for Revelation Biosciences and 2 mentions for Imunon. Imunon's average media sentiment score of 0.25 beat Revelation Biosciences' score of -0.60 indicating that Imunon is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Revelation Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Imunon 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, REVB or IMNN? Revelation Biosciences has a beta of -0.08, suggesting that its share price is 108% less volatile than the S&P 500. Comparatively, Imunon has a beta of 1.93, suggesting that its share price is 93% more volatile than the S&P 500. SummaryImunon beats Revelation Biosciences on 9 of the 15 factors compared between the two stocks. Get Revelation Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for REVB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding REVB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart REVB vs. The Competition Export to ExcelMetricRevelation BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.36M$2.95B$5.54B$9.40BDividend YieldN/A2.44%3.75%4.03%P/E Ratio-0.0119.7528.0119.79Price / SalesN/A298.31432.5697.34Price / CashN/A42.5936.1658.27Price / Book0.117.678.125.65Net Income-$15.04M-$55.28M$3.25B$257.91M7 Day Performance5.73%4.85%1.64%3.35%1 Month Performance23.75%11.70%7.27%11.09%1 Year Performance-96.34%3.69%32.88%18.99% Revelation Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)REVBRevelation Biosciences0.9464 of 5 stars$2.95+3.9%N/A-96.5%$4.36MN/A-0.0110High Trading VolumeIMNNImunon2.0816 of 5 stars$0.73-7.6%$15.50+2,023.3%-61.1%$13.86MN/A-0.5430Analyst DowngradeRLYBRallybio2.6965 of 5 stars$0.34+2.3%$10.00+2,837.7%-66.9%$13.85M$848K-0.3140SYBXSynlogicN/A$1.19+0.8%N/A+8.7%$13.80M$10K-0.4780Gap UpAIMDAinos0.8244 of 5 stars$3.30+0.3%N/A-24.2%$13.79M$20K-0.5140TXMDTherapeuticsMD0.0881 of 5 stars$1.17-0.8%N/A-36.5%$13.66M$1.76M0.00420Positive NewsTRIBTrinity Biotech0.4657 of 5 stars$0.73-2.0%N/A-76.3%$13.54M$61.56M-0.26480NKGNNKGen Biotech0.3236 of 5 stars$0.30flatN/A-78.4%$13.48MN/A-0.06N/ANews CoverageFLGCFlora Growth1.7095 of 5 stars$0.58-1.9%$4.00+584.9%-42.9%$13.43M$59.51M-0.60280NEUPNeuphoria Therapeutics1.3255 of 5 stars$7.16+0.4%$21.00+193.3%N/A$13.40M$10K0.00N/ANews CoveragePositive NewsME23andMeN/A$0.50-35.3%N/A-94.7%$13.36M$208.78M-0.03770Gap DownHigh Trading Volume Related Companies and Tools Related Companies Imunon Competitors Rallybio Competitors Synlogic Competitors Ainos Competitors TherapeuticsMD Competitors Trinity Biotech Competitors NKGen Biotech Competitors Flora Growth Competitors Neuphoria Therapeutics Competitors 23andMe Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:REVB) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revelation Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revelation Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
